Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

T-Cell Depletion, Donor HSCT, and T-Cell Infusions in Treating Patients With Hematologic Cancer or Other Diseases

The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2013 by The Cleveland Clinic.
Recruitment status was  Active, not recruiting
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Jaroslaw Maciejewski, The Cleveland Clinic Identifier:
First received: January 1, 2008
Last updated: October 18, 2013
Last verified: October 2013
No Study Results Posted on for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)